Jim Simons Hcw Biologics Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding HCWB
# of Institutions
21Shares Held
1.1MCall Options Held
0Put Options Held
0-
High Tower Advisors, LLC Chicago, IL180KShares$142,0490.0% of portfolio
-
Avantax Planning Partners, Inc.180KShares$142,0230.01% of portfolio
-
Geode Capital Management, LLC Boston, MA174KShares$137,6840.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$104,2720.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL85.1KShares$67,2410.13% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $28.3M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...